The Latest Breaking News from FDA

Washington (AFP) - The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.

Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.

Although inflation has shown signs of easing, it remains elevated. Therefore, the possibility of further rate hikes remains. As fears of a recession rise, investors may consider buying fundamentally strong stocks NetScout Systems (NTCT), Central Puerto (CEPU), and Vanda Pharmaceuticals (VNDA), trading at discounts to their peers. Keep reading….

Court upheld part of a Texas judge's ruling halting FDA decision allowing mifepristone to be distributed by mail

Washington (AFP) - A US appeals court has blocked moves to ban a widely-used abortion pill -- but imposed tough restrictions on access, in the latest round of an intensifying battle over reproductive rights.

Several FDA staffers were leaning toward rejecting a highly watched gene therapy from Sareptas, according to a report Thursday.

A federal appeals court partly granted the Biden administration’s request to put on hold a Texas court ruling overturning FDA approval of the abortion pill, but allowed restrictions that were lifted since 2016 to be reinstated.

Plus: New developments in the Texas abortion drug ruling, fallout from the Riley Gaines event at SFSU, and more...

At the heart of the latest battle over abortion access is a federal judge’s ruling that cites concern about the mental health of women who choose to end their pregnancies.

Mifepristone will remain on the market, but approved only for use up to seven weeks of pregnancy, versus 10 weeks, and it cannot be prescribed by telehealth or mailed, which were already illegal in Texas.

Washington (AFP) - The abortion pill mifepristone will remain temporarily available in the United States, but under tighter regulations, after a ruling by a federal appeals court late Wednesday.